GSE19615
Breat cancer dataset (Nat Med. 2011, 115 patients)
| SUBTYPE | SUBTYPE2 | SUBTYPE3 | adjuvant chemotherapy | age | chemo class | distant recur (yn) | distant recurrence free survival (mo) | er | grade (modified, bloom, richardson) | her.2 | histology type | hormonal rx | lymph nodes | patientid | pr | time of followup (mo) | tissue | tumor recurrence (36mo) | tumor size (cm) | adjuvant chemotherapy2 | TIME | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GSM491175 | HER2+ | HER2+ | ER-/HER2+ | AC-taxol | 53 | Anthracycline-based | Y | 24 | neg | III | pos (3+) | Ductal | none | positive | 292 | neg | NaN | breast tumor tissue | yes | 2.3 | Yes | 24 |
| GSM491176 | TNBC | TNBC | TNBC | AC x 4 | 60 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 310 | neg | 38 | breast tumor tissue | no | 0.9 | Yes | 38 |
| GSM491177 | TNBC | TNBC | TNBC | AC x 4 | 65 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 316 | neg | 60 | breast tumor tissue | no | 3.5 | Yes | 60 |
| GSM491178 | HER2+ | HER2+ | ER-/HER2+ | AC-taxol(x1) | 48 | Anthracycline-based | Y | 9 | neg | III | pos (3+) | Ductal | none | positive | 325 | neg | NaN | breast tumor tissue | yes | 1.8 | Yes | 9 |
| GSM491179 | TNBC | TNBC | TNBC | AC-taxol | 58 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | positive | 330 | neg | 62 | breast tumor tissue | no | 2.1 | Yes | 62 |
| GSM491180 | HER2+ | HER2+ | ER-/HER2+ | AC-taxol | 45 | Anthracycline-based | Y | 16 | neg | III | pos (3+) | Ductal | none | positive | 343 | neg | NaN | breast tumor tissue | yes | 2.5 | Yes | 16 |
| GSM491181 | TNBC | TNBC | TNBC | AC x 4 | 49 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | positive | 390 | neg | 64 | breast tumor tissue | no | 1.2 | Yes | 64 |
| GSM491182 | HER2+ | HER2+ | ER-/HER2+ | AC x 4 | 56 | Anthracycline-based | N | NaN | neg | III | pos (3+) | Ductal | none | negative | 397 | neg | 67 | breast tumor tissue | no | 2.1 | Yes | 67 |
| GSM491183 | HER2+ | HER2+ | ER-/HER2+ | AC x 4 | 85 | Anthracycline-based | Y | 27 | neg | II | pos (3+) | Ductal | none | positive | 400 | neg | NaN | breast tumor tissue | yes | 2.5 | Yes | 27 |
| GSM491184 | TNBC | TNBC | TNBC | AC x 4 | 66 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 451 | neg | 62 | breast tumor tissue | no | 2.5 | Yes | 62 |
| GSM491185 | TNBC | TNBC | TNBC | Unknown | 58 | Unknown | N | NaN | neg | II | neg | Ductal | none | negative | 488 | neg | 52 | breast tumor tissue | no | 1.8 | No | 52 |
| GSM491186 | TNBC | TNBC | TNBC | none | 79 | none | Y | 1 | neg | III | neg | Ductal | none | negative | 498 | neg | NaN | breast tumor tissue | yes | 5 | No | 1 |
| GSM491187 | TNBC | TNBC | TNBC | Epirubicin, Cytoxan, Xeloda | 58 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 534 | neg | 53 | breast tumor tissue | no | 2.1 | Yes | 53 |
| GSM491188 | TNBC | TNBC | TNBC | Unknown | 48 | Unknown | N | NaN | neg | III | neg | Ductal | none | negative | 538 | neg | 54 | breast tumor tissue | no | 1 | No | 54 |
| GSM491189 | TNBC | TNBC | TNBC | AC x 4 | 50 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 554 | neg | 51 | breast tumor tissue | no | 0.9 | Yes | 51 |
| GSM491190 | TNBC | TNBC | TNBC | AC x 4 | 40 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 558 | neg | 48 | breast tumor tissue | no | 2.2 | Yes | 48 |
| GSM491191 | TNBC | TNBC | TNBC | AC x 4 | 58 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 582 | neg | 52 | breast tumor tissue | no | 1 | Yes | 52 |
| GSM491192 | HER2+ | HER2+ | ER-/HER2+ | AC-taxol/Herceptin | 63 | Trastuzumab | N | NaN | neg | III | pos (3+) | Ductal | none | positive | 588 | neg | 50 | breast tumor tissue | no | 3.5 | Yes | 50 |
| GSM491193 | TNBC | TNBC | TNBC | AC-taxol | 41 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 591 | neg | 50 | breast tumor tissue | no | 2.7 | Yes | 50 |
| GSM491194 | TNBC | TNBC | TNBC | none | 74 | none | N | NaN | neg | II | neg | Ductal | none | negative | 598 | neg | 40 | breast tumor tissue | no | 2.5 | No | 40 |
| GSM491195 | TNBC | TNBC | TNBC | AC x 4 | 48 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 609 | neg | 49 | breast tumor tissue | no | 3 | Yes | 49 |
| GSM491196 | TNBC | TNBC | TNBC | none | 78 | none | N | NaN | neg | III | neg | Ductal | none | negative | 613 | neg | 53 | breast tumor tissue | no | 1.3 | No | 53 |
| GSM491197 | TNBC | TNBC | TNBC | AC x 4 | 55 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 653 | neg | 50 | breast tumor tissue | no | 1.4 | Yes | 50 |
| GSM491198 | TNBC | TNBC | TNBC | AC x 4 | 43 | Anthracycline-based | Y | 35 | neg | III | neg | Ductal | none | negative | 664 | neg | NaN | breast tumor tissue | yes | 1.7 | Yes | 35 |
| GSM491199 | TNBC | TNBC | TNBC | none | 72 | none | N | NaN | neg | III | neg | Ductal | none | negative | 665 | neg | 50 | breast tumor tissue | no | 2.3 | No | 50 |
| GSM491200 | HER2+ | HER2+ | ER-/HER2+ | AC-taxol | 49 | Anthracycline-based | N | NaN | neg | III | pos (3+) | Ductal | none | positive | 670 | neg | 36 | breast tumor tissue | no | 3.4 | Yes | 36 |
| GSM491201 | TNBC | TNBC | TNBC | CAF | 43 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 799 | neg | 36 | breast tumor tissue | no | 2.8 | Yes | 36 |
| GSM491202 | TNBC | TNBC | TNBC | AC-taxotere | 56 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 828 | neg | 39 | breast tumor tissue | no | 2.2 | Yes | 39 |
| GSM491203 | HER2+ | ER+ | ER+/HER2+ | AC x 4 | 41 | Anthracycline-based | N | NaN | pos | III | pos (3+) | Ductal | Tam | positive | 396 | pos | 65 | breast tumor tissue | no | 1.1 | Yes | 65 |
| GSM491204 | ER+ | ER+ | ER+ | AC x 4 | 62 | Anthracycline-based | N | NaN | pos | I | neg | Lobular | Tam | negative | 92 | pos | 80 | breast tumor tissue | no | 3.5 | Yes | 80 |
| GSM491205 | HER2+ | ER+ | ER+/HER2+ | Unknown | 43 | Unknown | N | NaN | pos | III | pos (3+) | Ductal | unknown | negative | 129 | pos | 78 | breast tumor tissue | no | 1 | No | 78 |
| GSM491206 | HER2+ | ER+ | ER+/HER2+ | none | 54 | none | N | NaN | pos | I | low pos (2+) | Ductal | Tam | negative | 131 | pos | 78 | breast tumor tissue | no | 1.7 | No | 78 |
| GSM491207 | HER2+ | HER2+ | None | AC x 4 | 55 | Anthracycline-based | N | NaN | pos-low | III | pos (3+) | Ductal | Tam | positive | 96 | pos-low | 51 | breast tumor tissue | no | 1.4 | Yes | 51 |
| GSM491208 | ER+ | ER+ | ER+ | CMF | 46 | Other | Y | 6 | pos | II | neg | Mixed | Tam | positive | 86 | pos | NaN | breast tumor tissue | yes | 2.6 | Yes | 6 |
| GSM491209 | ER+ | ER+ | ER+ | AC x 4 | 46 | Anthracycline-based | N | NaN | pos | II | neg | Mixed | Tam | negative | 73 | pos | 85 | breast tumor tissue | no | 0.9 | Yes | 85 |
| GSM491210 | ER+ | ER+ | ER+ | none | 44 | none | N | NaN | pos | I | neg | Ductal | Tam | negative | 212 | pos | 73 | breast tumor tissue | no | 0.8 | No | 73 |
| GSM491211 | HER2+ | ER+ | ER+/HER2+ | AC x 4 | 54 | Anthracycline-based | N | NaN | pos | II | pos (3+) | Ductal | Tam | negative | 74 | pos-low | 82 | breast tumor tissue | no | 2.2 | Yes | 82 |
| GSM491212 | HER2+ | HER2+ | ER-/HER2+ | AC x 4 | 49 | Anthracycline-based | N | NaN | neg | III | pos (3+) | Ductal | none | negative | 196 | neg | 75 | breast tumor tissue | no | 1.8 | Yes | 75 |
| GSM491213 | ER+ | ER+ | ER+ | none | 84 | none | N | NaN | pos | II | neg | Mixed | Tam | positive | 123 | pos | 79 | breast tumor tissue | no | 2.2 | No | 79 |
| GSM491214 | HER2+ | ER+ | ER+/HER2+ | AC x 4 | 43 | Anthracycline-based | N | NaN | pos | III | pos (3+) | Ductal | Tam | negative | 180 | neg | 52 | breast tumor tissue | no | 4.2 | Yes | 52 |
| GSM491215 | HER2+ | HER2+ | ER-/HER2+ | AC x 4 | 54 | Anthracycline-based | N | NaN | neg | II | pos (3+) | Ductal | none | negative | 249 | neg | 81 | breast tumor tissue | no | 2.5 | Yes | 81 |
| GSM491216 | ER+ | ER+ | ER+ | none | 45 | none | N | NaN | pos | II | neg | Lobular | Tam | negative | 207 | pos | 59 | breast tumor tissue | no | 2.3 | No | 59 |
| GSM491217 | HER2+ | HER2+ | None | AC-taxotere | 45 | Anthracycline-based | N | NaN | pos-low | II | pos (3+) | Ductal | Tam | positive | 65 | pos-low | 83 | breast tumor tissue | no | 1.7 | Yes | 83 |
| GSM491218 | ER+ | ER+ | ER+ | AC x 4 | 35 | Anthracycline-based | N | NaN | pos | II | neg | Lobular | Tam | positive | 157 | neg | 85 | breast tumor tissue | no | 1.1 | Yes | 85 |
| GSM491219 | TNBC | TNBC | TNBC | AC x 4 | 53 | Anthracycline-based | Y | 18 | neg | III | neg | Ductal | none | negative | 148 | neg | NaN | breast tumor tissue | yes | 3 | Yes | 18 |
| GSM491220 | ER+ | ER+ | ER+ | AC x 4 | 60 | Anthracycline-based | N | NaN | pos | I | neg | Ductal | Tam | negative | 228 | pos-low | 70 | breast tumor tissue | no | 2.3 | Yes | 70 |
| GSM491221 | ER+ | ER+ | ER+ | AC-taxol | 32 | Anthracycline-based | N | NaN | pos | II | neg | Ductal | Tam | positive | 162 | pos-low | 83 | breast tumor tissue | no | 1.5 | Yes | 83 |
| GSM491222 | ER+ | ER+ | ER+ | AC-taxol | 40 | Anthracycline-based | N | NaN | pos | I | neg | Ductal | Tam | positive | 175 | neg | 74 | breast tumor tissue | no | 4 | Yes | 74 |
| GSM491223 | HER2+ | HER2+ | ER-/HER2+ | AC x 4 | 45 | Anthracycline-based | N | NaN | neg | III | pos (3+) | Ductal | none | negative | 14 | neg | 87 | breast tumor tissue | no | 1.5 | Yes | 87 |
| GSM491224 | ER+ | ER+ | ER+ | AC x 4 | 46 | Anthracycline-based | N | NaN | pos | I | neg | Ductal | none | negative | 246 | pos | 86 | breast tumor tissue | no | 1.1 | Yes | 86 |
| GSM491225 | ER+ | ER+ | ER+ | AC-taxol | 41 | Anthracycline-based | N | NaN | pos | I | neg | Ductal | Tam | positive | 60 | pos | 86 | breast tumor tissue | no | 3 | Yes | 86 |
| GSM491226 | HER2+ | ER+ | ER+/HER2+ | AC-taxol | 46 | Anthracycline-based | N | NaN | pos | III | low pos (2+) | Lobular | Tam | positive | 138 | pos | 80 | breast tumor tissue | no | 2.3 | Yes | 80 |
| GSM491227 | ER+ | ER+ | ER+ | AC x 4 | 36 | Anthracycline-based | N | NaN | pos | II | neg | Ductal | Tam | negative | 204 | pos | 78 | breast tumor tissue | no | 1 | Yes | 78 |
| GSM491228 | TNBC | TNBC | TNBC | Unknown | 68 | Unknown | N | NaN | neg | III | neg | Ductal | unknown | negative | 239 | neg | 73 | breast tumor tissue | no | 1.1 | No | 73 |
| GSM491229 | TNBC | TNBC | TNBC | AC x 4 | 54 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 253 | neg | 56 | breast tumor tissue | no | 1.1 | Yes | 56 |
| GSM491230 | ER+ | ER+ | ER+ | none | 81 | none | N | NaN | pos | I | neg | Lobular | Tam | positive | 11 | pos-low | 70 | breast tumor tissue | no | 2.5 | No | 70 |
| GSM491231 | HER2+ | HER2+ | ER-/HER2+ | AC-taxol | 45 | Anthracycline-based | N | NaN | neg | III | low pos (2+) | Ductal | none | positive | 21 | neg | 83 | breast tumor tissue | no | 3 | Yes | 83 |
| GSM491232 | TNBC | TNBC | TNBC | AC x 2, Taxol | 53 | Anthracycline-based | Y | 14 | neg | III | neg | Lobular | none | positive | 214 | neg | NaN | breast tumor tissue | yes | 5.2 | Yes | 14 |
| GSM491233 | TNBC | TNBC | TNBC | AC x 4 | 48 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 12 | neg | 75 | breast tumor tissue | no | 2.5 | Yes | 75 |
| GSM491234 | ER+ | ER+ | ER+ | AC x 4 | 53 | Anthracycline-based | N | NaN | pos | II | neg | Lobular | Tam | negative | 165 | neg | 77 | breast tumor tissue | no | 2.5 | Yes | 77 |
| GSM491235 | HER2+ | ER+ | ER+/HER2+ | AC-taxol.taxotere | 57 | Anthracycline-based | N | NaN | pos | III | low pos (2+) | Ductal | Tam | positive | 126 | pos | 73 | breast tumor tissue | no | 1.7 | Yes | 73 |
| GSM491236 | ER+ | ER+ | ER+ | AC x 4 | 57 | Anthracycline-based | N | NaN | pos | II | neg | Ductal | Tam | negative | 6 | pos | 59 | breast tumor tissue | no | 2.1 | Yes | 59 |
| GSM491237 | ER+ | ER+ | ER+ | AC-taxol | 46 | Anthracycline-based | N | NaN | pos | III | neg | Ductal | Tam | positive | 58 | pos-low | 85 | breast tumor tissue | no | 1.5 | Yes | 85 |
| GSM491238 | HER2+ | HER2+ | ER-/HER2+ | AC x 4 | 50 | Anthracycline-based | N | NaN | neg | III | low pos (2+) | Ductal | none | negative | 164 | neg | 77 | breast tumor tissue | no | 1.9 | Yes | 77 |
| GSM491239 | ER+ | ER+ | ER+ | AC-taxol | 58 | Anthracycline-based | N | NaN | pos | II | neg | Mixed | Tam | positive | 119 | pos | 81 | breast tumor tissue | no | 3.5 | Yes | 81 |
| GSM491240 | ER+ | ER+ | ER+ | none | 62 | none | N | NaN | pos | I | neg | Ductal | Tam | negative | 154 | pos | 81 | breast tumor tissue | no | 1.5 | No | 81 |
| GSM491241 | TNBC | TNBC | TNBC | AC x 4 | 44 | Anthracycline-based | N | NaN | neg | III | neg | Ductal | none | negative | 182 | neg | 57 | breast tumor tissue | no | 2 | Yes | 57 |
| GSM491242 | HER2+ | ER+ | ER+/HER2+ | AC-taxol | 37 | Anthracycline-based | N | NaN | pos | II | pos (3+) | Ductal | Tam | positive | 35 | pos | 48 | breast tumor tissue | no | 1.3 | Yes | 48 |
| GSM491243 | HER2+ | HER2+ | ER-/HER2+ | AC-taxol | 55 | Anthracycline-based | N | NaN | neg | III | pos (3+) | Ductal | none | positive | 151 | neg | 58 | breast tumor tissue | no | 2.5 | Yes | 58 |
| GSM491244 | TNBC | TNBC | TNBC | none | 64 | none | Y | 21 | neg | III | neg | Ductal | none | negative | 203 | neg | NaN | breast tumor tissue | yes | 1.7 | No | 21 |
| GSM491245 | HER2+ | HER2+ | ER-/HER2+ | AC x 4 | 53 | Anthracycline-based | N | NaN | neg | III | pos (3+) | Ductal | none | negative | 187 | neg | 77 | breast tumor tissue | no | 3 | Yes | 77 |
| GSM491246 | NaN | NaN | NaN | AC x 4 | 66 | Anthracycline-based | N | NaN | pos-low | I | neg | Ductal | Tam | positive | 237 | pos | 82 | breast tumor tissue | no | 1.1 | Yes | 82 |
| GSM491247 | HER2+ | ER+ | ER+/HER2+ | none | 63 | none | N | NaN | pos | III | pos (3+) | Ductal | none | negative | 238 | pos | 71 | breast tumor tissue | no | 1.2 | No | 71 |
| GSM491248 | ER+ | ER+ | ER+ | none | 66 | none | N | NaN | pos | I | neg | Ductal | Tam | positive | 252 | pos | 55 | breast tumor tissue | no | 1.2 | No | 55 |
| GSM491249 | NaN | NaN | NaN | none | 38 | none | Y | 2 | pos-low | III | neg | Mixed | none | positive | 206 | pos-low | NaN | breast tumor tissue | yes | 4.2 | No | 2 |
| GSM491250 | ER+ | ER+ | ER+ | AC-taxol | 46 | Anthracycline-based | N | NaN | pos | III | neg | Ductal | Tam | positive | 230 | pos | 76 | breast tumor tissue | no | 3 | Yes | 76 |
| GSM491251 | ER+ | ER+ | ER+ | AC-taxol | 60 | Anthracycline-based | N | NaN | pos | III | neg | Ductal | Tam | positive | 142 | pos | 88 | breast tumor tissue | no | 2.2 | Yes | 88 |
| GSM491252 | ER+ | ER+ | ER+ | AC-taxol | 50 | Anthracycline-based | N | NaN | pos | I | neg | Ductal | Tam | positive | 168 | pos | 47 | breast tumor tissue | no | 1.3 | Yes | 47 |
| GSM491253 | ER+ | ER+ | ER+ | AC-taxol | 37 | Anthracycline-based | N | NaN | pos | I | neg | Ductal | Tam | positive | 222 | pos | 83 | breast tumor tissue | no | 1.2 | Yes | 83 |
| GSM491254 | HER2+ | ER+ | ER+/HER2+ | Unknown | 53 | Unknown | N | NaN | pos | III | pos (3+) | Ductal | Tam | negative | 219 | pos-low | 54 | breast tumor tissue | no | 2 | No | 54 |
| GSM491255 | ER+ | ER+ | ER+ | none | 57 | none | N | NaN | pos | I | neg | Mixed | Tam | negative | 91 | neg | 79 | breast tumor tissue | no | 1.1 | No | 79 |
| GSM491256 | HER2+ | HER2+ | ER-/HER2+ | AC-taxol | 57 | Anthracycline-based | Y | 15 | neg | II | pos (3+) | Ductal | none | positive | 156 | neg | NaN | breast tumor tissue | yes | 2.9 | Yes | 15 |
| GSM491257 | ER+ | ER+ | ER+ | none | 84 | none | Y | 18 | pos | III | neg | Ductal | Tam | positive | 227 | pos | NaN | breast tumor tissue | yes | 2.5 | No | 18 |
| GSM491258 | ER+ | ER+ | ER+ | CMF | 46 | Other | N | NaN | pos | II | neg | Lobular | Tam | negative | 177 | pos | 76 | breast tumor tissue | no | 1.2 | Yes | 76 |
| GSM491259 | ER+ | ER+ | ER+ | AC-taxol | 45 | Anthracycline-based | N | NaN | pos | I | neg | Lobular | Tam | positive | 231 | pos | 81 | breast tumor tissue | no | 1.5 | Yes | 81 |
| GSM491260 | ER+ | ER+ | ER+ | none | 62 | none | N | NaN | pos | I | neg | Lobular | Tam | negative | 150 | pos | 83 | breast tumor tissue | no | 5 | No | 83 |
| GSM491261 | ER+ | ER+ | ER+ | AC-taxol | 58 | Anthracycline-based | N | NaN | pos | I | neg | Mixed | Tam | positive | 221 | pos | 54 | breast tumor tissue | no | 1.5 | Yes | 54 |
| GSM491262 | ER+ | ER+ | ER+ | none | 50 | none | N | NaN | pos | I | neg | Ductal | Tam | negative | 174 | pos-low | 79 | breast tumor tissue | no | 1.4 | No | 79 |
| GSM491263 | ER+ | ER+ | ER+ | none | 74 | none | N | NaN | pos | I | neg | Ductal | Tam | negative | 178 | pos | 74 | breast tumor tissue | no | 1.1 | No | 74 |
| GSM491264 | ER+ | ER+ | ER+ | none | 57 | none | N | NaN | pos | III | neg | Ductal | Tam | positive | 192 | pos | 74 | breast tumor tissue | no | 1.1 | No | 74 |
| GSM491265 | ER+ | ER+ | ER+ | none | 58 | none | N | NaN | pos | I | neg | Ductal | Tam | negative | 87 | neg | 81 | breast tumor tissue | no | 0.8 | No | 81 |
| GSM491266 | ER+ | ER+ | ER+ | none | 59 | none | N | NaN | pos | I | neg | Lobular | Tam | negative | 7 | pos | 81 | breast tumor tissue | no | 1 | No | 81 |
| GSM491267 | ER+ | ER+ | ER+ | AC-taxol | 46 | Anthracycline-based | N | NaN | pos | II | neg | Ductal | Tam | negative | 229 | pos | 76 | breast tumor tissue | no | 2.1 | Yes | 76 |
| GSM491268 | HER2+ | ER+ | ER+/HER2+ | none | 54 | none | N | NaN | pos | II | low pos (2+) | Ductal | Tam | negative | 9 | pos-low | 65 | breast tumor tissue | no | 1.5 | No | 65 |
| GSM491269 | ER+ | ER+ | ER+ | none | 64 | none | N | NaN | pos | I | neg | Mixed | Tam | negative | 224 | pos | 83 | breast tumor tissue | no | 1.3 | No | 83 |
| GSM491270 | HER2+ | ER+ | ER+/HER2+ | AC x 4 | 64 | Anthracycline-based | N | NaN | pos | III | pos (3+) | Ductal | Arimidex | negative | 666 | pos | 48 | breast tumor tissue | no | 2.1 | Yes | 48 |
| GSM491271 | HER2+ | HER2+ | ER-/HER2+ | AC-taxol | 68 | Anthracycline-based | N | NaN | neg | III | pos (3+) | Mixed | none | positive | 643 | neg | 51 | breast tumor tissue | no | 5.5 | Yes | 51 |
| GSM491272 | ER+ | ER+ | ER+ | CMF | 49 | Other | N | NaN | pos | I | neg | Mixed | Tam | pos.micromet | 552 | pos | 56 | breast tumor tissue | no | 2 | Yes | 56 |
| GSM491273 | ER+ | ER+ | ER+ | CAF | 37 | Anthracycline-based | N | NaN | pos | II | neg | Ductal | Tam | positive | 489 | pos | 59 | breast tumor tissue | no | 6.5 | Yes | 59 |
| GSM491274 | ER+ | ER+ | ER+ | CMF | 63 | Other | N | NaN | pos | III | neg | Ductal | Tam | positive | 362 | pos | 69 | breast tumor tissue | no | 4.5 | Yes | 69 |
| GSM491275 | HER2+ | ER+ | ER+/HER2+ | none | 71 | none | N | NaN | pos | III | pos (3+) | Lobular | Tam | positive | 537 | pos | 71 | breast tumor tissue | no | 2.3 | No | 71 |
| GSM491276 | ER+ | ER+ | ER+ | AC-taxol | 45 | Anthracycline-based | N | NaN | pos | II | neg | Lobular | Tam | positive | 651 | pos | 53 | breast tumor tissue | no | 4 | Yes | 53 |
| GSM491277 | ER+ | ER+ | ER+ | none | 78 | none | N | NaN | pos | III | neg | Ductal | Arimidex | positive | 365 | pos | 53 | breast tumor tissue | no | 2.3 | No | 53 |
| GSM491278 | ER+ | ER+ | ER+ | CAF | 49 | Anthracycline-based | N | NaN | pos | III | neg | Ductal | Tam | pos.micromet | 612 | pos | 53 | breast tumor tissue | no | 5.6 | Yes | 53 |
| GSM491279 | HER2+ | ER+ | ER+/HER2+ | AC-taxol/Herceptin | 42 | Trastuzumab | N | NaN | pos | III | pos (3+) | Ductal | Tam | positive | 656 | neg | 54 | breast tumor tissue | no | 4 | Yes | 54 |
| GSM491280 | ER+ | ER+ | ER+ | none | 54 | none | N | NaN | pos | II | neg | Ductal | Tam | negative | 254 | pos | 71 | breast tumor tissue | no | 2.5 | No | 71 |
| GSM491281 | ER+ | ER+ | ER+ | none | 82 | none | N | NaN | pos | II | neg | Ductal | Tam | positive | 260 | pos | 48 | breast tumor tissue | no | 2.5 | No | 48 |
| GSM491282 | ER+ | ER+ | ER+ | AC-taxotere | 48 | Anthracycline-based | N | NaN | pos | III | neg | Mixed | unknown | positive | 262 | pos | 71 | breast tumor tissue | no | 5 | Yes | 71 |
| GSM491283 | HER2+ | ER+ | ER+/HER2+ | AC x 4 | 49 | Anthracycline-based | N | NaN | pos | III | pos (3+) | Ductal | Tam | negative | 274 | pos | 71 | breast tumor tissue | no | 3 | Yes | 71 |
| GSM491284 | NaN | NaN | NaN | AC-taxol | 45 | Anthracycline-based | N | NaN | neg | II | neg | Ductal | none | positive | 281 | pos | 74 | breast tumor tissue | no | 1.2 | Yes | 74 |
| GSM491285 | HER2+ | ER+ | ER+/HER2+ | Unknown | 47 | Unknown | N | NaN | pos | III | pos (3+) | Ductal | unknown | positive | 283 | pos | 36 | breast tumor tissue | no | 4 | No | 36 |
| GSM491286 | ER+ | ER+ | ER+ | AC x 4 | 56 | Anthracycline-based | Y | 18 | pos | II | neg | Lobular | Tam | negative | 300 | pos | NaN | breast tumor tissue | yes | 1.6 | Yes | 18 |
| GSM491287 | HER2+ | ER+ | ER+/HER2+ | AC x 4 | 45 | Anthracycline-based | N | NaN | pos | III | pos (3+) | Ductal | Tam | negative | 308 | pos | 73 | breast tumor tissue | no | 1.9 | Yes | 73 |
| GSM491288 | ER+ | ER+ | ER+ | AC x 4 | 41 | Anthracycline-based | N | NaN | pos | III | neg | Ductal | Tam | positive | 363 | pos-low | 67 | breast tumor tissue | yes | 4 | Yes | 67 |
| GSM491289 | HER2+ | ER+ | ER+/HER2+ | AC-taxol/Herceptin | 32 | Trastuzumab | N | NaN | pos | II | pos (3+) | Mixed | Tam | positive | 621 | pos | 55 | breast tumor tissue | no | 4.5 | Yes | 55 |